Statistics from Altmetric.com
Zoetis has announced that the European Commission has granted marketing authorisation for Simparica chewable tablets, containing the active ingredient sarolaner. The product is indicated for the once-monthly treatment of fleas, ticks and sarcoptic mange in dogs from eight weeks of age. The company says it expects to launch Simparica in the EU in the first quarter of 2016.
Zoetis explains …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.